ValiRx plc(GB:VAL)
GBX 0.16-0.01 (-3.13%)
GB:VAL
ValiRx plc stock drug pipeline
GBX 0.16
At close:-0.01 (-3.13%)
Want to see GB:VAL full AI Analyst Report?
ValiRx plc (VAL) Drug Pipeline
7 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Val201 | Stage Iii Prostate Carcinoma, Stage Iv Prostate Carcinoma | phase1AndPhase2 | Completed | Dose Finding Safety Study of VAL201 in Cancer Patients | Oct 20, 2014 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Val201 | phase1AndPhase2 | Stage Iii Prostate Carcinoma, Stage Iv Prostate Carcinoma | Completed | Dose Finding Safety Study of VAL201 in Cancer Patients | Oct 20, 2014 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does ValiRx plc (GB:VAL) have in its pipeline
ValiRx plc GB:VAL is currently developing the following drugs: Val201. These drug candidates are in various stages of clinical development as the company works toward FDA approval.

